Madam Speaker, Health Canada's priority review program exists to allow the expedited review of new, potentially life-saving, therapies. Qualifying drug submissions are able to seek approval for therapeutic use in advance of other, less urgent therapies. Health Canada's posted timeframe for this expedited process is a target of 180 calendar days.
How often is Health Canada meeting this target? How often has this target been missed in each of the years since the priority review program was established?